Treatment of Oral Thrush in Infants
Oral nystatin suspension at a dose of 1 mL (100,000 units) four times daily for at least 48 hours after symptoms resolve is the first-line treatment for oral thrush in infants. 1, 2
First-Line Treatment: Nystatin Oral Suspension
Dosing and Administration
- Standard dosage: 2 mL (200,000 units) four times daily 2
- For premature and low birth weight infants: 1 mL (100,000 units) four times daily 1, 2
- Administration technique:
- Use dropper to place half of dose in each side of mouth
- Avoid feeding for 5-10 minutes after administration
- Continue treatment for at least 48 hours after symptoms disappear 2
Efficacy and Considerations
- Nystatin works locally in the oral cavity without systemic absorption 1
- Treatment response should be assessed after 2-3 days 1
- Common causes of treatment failure include:
- Inadequate duration of therapy
- Poor administration technique
- Failure to address potential sources of reinfection
- Premature discontinuation of treatment 1
Second-Line Treatment: Fluconazole
Consider fluconazole in cases where:
- Nystatin treatment has failed
- Severe infection is present
Dosing Options
- 3 mg/kg once daily for 7 days 1, 3
- Alternative: 15 mg every 8 hours (less recommended due to resistance concerns) 1
Efficacy Comparison
Fluconazole has demonstrated superior efficacy in some studies:
- In a small pilot study, fluconazole achieved 100% clinical cure rate compared to 32% with nystatin suspension 3
- However, fluconazole use is limited by concerns about developing triazole resistance 1
Prevention of Reinfection
During Treatment
- Sterilize pacifiers and bottle nipples regularly 1
- If breastfeeding, treat mother's nipples simultaneously if candidiasis is present 1, 4
Prophylaxis in High-Risk Settings
- In nurseries with high rates (>10%) of invasive candidiasis:
Treatment Duration and Follow-up
- Continue treatment for at least 48 hours after perioral symptoms have disappeared 1, 2
- Verify eradication with cultures when possible 2
- Monitor for recurrence, especially in immunocompromised infants 7
Common Pitfalls to Avoid
- Stopping treatment too early (before complete resolution)
- Inadequate application technique (not placing medication in contact with affected areas)
- Failing to identify and treat maternal breast infection in breastfeeding dyads
- Not addressing environmental sources of reinfection (pacifiers, bottle nipples)
- Overlooking the need for different dosing in premature or low birth weight infants